๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Brainstem tumor presenting with unilateral astereognosis

โœ Scribed by Moshe Feinsod; Shlomo Bentin; Morris Moscovitch; Uri Wald

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
220 KB
Volume
8
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

A patient with a brainstem tumor presented with astereognosis. The results of CT scan, evoked response studies, and neuropsychological tests all were consistent with a noncortical origin for the sensory defect.

๐Ÿ“œ SIMILAR VOLUMES

Adenocarcinoid tumor of appendix present
Adenocarcinoid tumor of appendix presenting as unilateral krukenberg tumor
โœ Rodney T. Miller; Huseyin Sarikaya; Eric L. Jenison ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 580 KB

We report a case of adenocarcinoid tumor of the appendix that presented initially as a unilateral Krukenberg tumor (a signet ring cell mucinous adenocarcinoma with prominent cellular stroma). The primary tumor in the appendix was discovered 10 months later at the time of a "second look" laparotomy.

Antigen-presenting cells pulsed with unf
Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines
โœ Smita K. Nair; David Boczkowski; David Snyder; Eli Gilboa ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 920 KB

Vaccination with peptides isolated from tumor cells circumvents the need for identifying specific tumor rejection antigens and extends the use of active immunotherapy to the majority of cancers where specific tumor antigens have not yet been identified. In this study, we examined the efficacy of tum

Regression of tumors in mice vaccinated
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
โœ Smita K. Nair; David Snyder; Barry T. Rouse; Eli Gilboa ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 211 KB ๐Ÿ‘ 2 views

Vaccination with tumor extracts circumvents the need to identify specific tumor rejection antigens and extends the use of active immunotherapy to the vast majority of cancers, in which specific tumor antigens have not yet been identified. In this study we examined the efficacy of tumor vaccines comp